---
title: "Wanchen Biotechnology: Plans to donate 5 million yuan to the Jiangsu Provincial Charity Federation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264158768.md"
description: "Wanchen Biotechnology announced that the company held the 39th meeting of the fourth board of directors on November 4, 2025, and approved the proposal on external donations. The company plans to sign an agreement with the Jiangsu Provincial Charity Federation, whereby the company or its holding subsidiary will donate RMB 5 million to the Jiangsu Provincial Charity Federation. This external donation does not involve related party transactions and does not constitute a major asset reorganization as defined by the Administrative Measures for Major Asset Restructuring of Listed Companies"
datetime: "2025-11-04T07:55:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264158768.md)
  - [en](https://longbridge.com/en/news/264158768.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264158768.md)
---

# Wanchen Biotechnology: Plans to donate 5 million yuan to the Jiangsu Provincial Charity Federation

Wanchen Biotechnology announced that the company held the 39th meeting of the fourth board of directors on November 4, 2025, and approved the proposal on external donations. The company plans to sign an agreement with the Jiangsu Provincial Charity Association, whereby the company or its holding subsidiary will donate RMB 5 million to the Jiangsu Provincial Charity Association. This external donation does not involve related party transactions and does not constitute a major asset reorganization as defined by the Administrative Measures for Major Asset Restructuring of Listed Companies

### Related Stocks

- [300972.CN](https://longbridge.com/en/quote/300972.CN.md)

## Related News & Research

- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [Israel-based Phase 3 ocular diseases biotech Tarsier Pharma sets terms for $45 million US IPO](https://longbridge.com/en/news/286793435.md)
- [Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer](https://longbridge.com/en/news/286856224.md)
- [VERTANICAL’s VER-01 gains FDA breakthrough status for low back pain](https://longbridge.com/en/news/286901967.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)